College of Medicine & Dentistry
Semagn Abate
- Doctor of Philosophy (Health)
- semagn.abate@my.jcu.edu.au
Joseph Kamara
- Senior Lecturer Disaster Health and Humanitarian Assistance
- joseph.kamara@jcu.edu.au
Eric Kalo
- Lecturer Medical Education
- eric.kalo@jcu.edu.au
Erin Waters
- JCU Associate Professor
- erin.waters@jcu.edu.au
Kannan Maharajan
- Associate Professor, Pharmacy
- kannan.maharajan@jcu.edu.au
Fahmida Begum Mina
- Doctor of Philosophy (Medical, Molecular and Veterinary Sciences)
- fahmidabegum.mina@my.jcu.edu.au
Lynsey Brown
- Adjunct Senior Lecturer
- lynsey.brown@jcu.edu.au
Ali Isin
- Adjunct Senior Research Fellow
- ali.isin@jcu.edu.au
Muideen Olaiya
- Senior Research Fellow
- muideen.olaiya@jcu.edu.au
Mila Grinblat
- Postdoctoral Research Fellow
- mila.grinblat@jcu.edu.au
Increased awareness of and access to diabetes and tuberculosis care in New Ireland Province of Papua New Guinea (Old ID 22317)
Venkat Vangaveti
01 Jul 2016 - 31 Mar 2021
The 3-year project is intended to (1) raise awareness of Diabetes and TB among the general populationin New Ireland Province (2) Train doctors, nurses, pharmacists and community health workers to effectively treat Diabetes and TB (3) Establish better monitoring of Diabetes and TB in remote areas with the help of electronic registry and mobile phone technology (4) conduct public health campaigns by the local health professionals and to screen and monitor the diseases with the help of mobile phone technology.
Antimicrobial peptide expression and metagenomic profiles of corals: a model for host microbiome interactions and a source of novel antibacterial medicines (Old ID 22908)
Jeffrey Warner
01 Sep 2016 - 31 Dec 2017
Antimicrobial peptide expression and metagenomic profiles of corals: a model for host microbiome interactions and a source of novel antibacterial medicines. The results from this grant also provide avenues to pursue further collaboration and grant funding in thearea of human health. This includes the results of aim 2 which has the potential to reveal targets forfurther development as antibacterial treatments. In addition, the techniques developed as part of aim 1could be effectively applied to explore the role of antimicrobial peptides in human gut microbiomedevelopment.This grant will add to a growing strength in proteomics and peptide characterisation research at JCU and will contribute to the collective track record required for collaborative funding bids such as LIEF funding for new mass spectrometry equipment.
Diabetes Collaborative Evaluation Project (Old ID 23599)
Karen Carlisle
01 Jul 2017 - 30 Jun 2018
The diabetes collaborative is a Continuous quality Improvement (CQI) approach to change that aims to improve health outcomes for patients diagnosed with Diabetes. It involves the introduction of a team-based, sustainable approach to learning whilst providing a sound understanding and application of quality improvement methodology and skills. This project aims to evaluate the implementation and outcomes of the WQPHN diabetes collaborative. Expected outcomes of the equation will be a greater understanding of the process of implementation and any changes within participant health services as a result of the collaborative. Evaluation of the program in the rural and remote context of WQPHN will inform on feasibility and effectiveness of this approach.
Diabetes Collaborative Evaluation Project (Old ID 23599)
Rebecca Evans
01 Jul 2017 - 30 Jun 2018
The diabetes collaborative is a Continuous quality Improvement (CQI) approach to change that aims to improve health outcomes for patients diagnosed with Diabetes. It involves the introduction of a team-based, sustainable approach to learning whilst providing a sound understanding and application of quality improvement methodology and skills. This project aims to evaluate the implementation and outcomes of the WQPHN diabetes collaborative. Expected outcomes of the equation will be a greater understanding of the process of implementation and any changes within participant health services as a result of the collaborative. Evaluation of the program in the rural and remote context of WQPHN will inform on feasibility and effectiveness of this approach.
Leveraging NQ telehealth experience for contextually-informed process guidelines to optimise health service access, quality and safety in rural and remote Australia
Karen Johnston
17 Sep 2024 - 16 Sep 2029
Use of telehealth in north Queensland has evolved early and rapidly in response to the health service needs of a culturally diverse population spread over a large area. This project maps knowledge about existing telehealth usage, examines strategies for safe and high quality use, including cultural acceptability and co-develops guidelines for health care providers and consumers for the optimal usage of telehealth across north Queensland. This is likely to be applicable across other RRR areas.
Seed funding -improving stroke management by characterising the ischaemic penumrba proteome.
Alex Trollope
01 Jul 2024 - 30 Jun 2025
Current therapies for stroke work by restoring the blood supply to the brain to rescue oxygen-starved tissue at risk of dying (known as the ischaemic penumbra). Consumer groups highlight that therapies to slow the death of cells in the penumbra is a priority, however, surprisingly little is known about the biology of this tissue. This study will utilise laboratory models of stroke, and apply modern imaging, proteomic and bioinformatic approaches to characterise the major pathways driving penumbra phenotype. Generated data will provide a world's first perspective into penumbra biology as an important foundation for subsequent grants seeking to test potential therapuetic targets.
Documenting Indigenous Plant Knowledge to Strengthen Conservation Management in Kwaio, Solomon Islands (Old ID 22880)
Michelle Redman-MacLaren
01 Sep 2016 - 01 Sep 2019
The project is designed to deliver ongoing capacity-strengthening activities and training in project management, organizational governance and financial management to enhance local conservation efforts in the central mountains of the island of Malaita, Solomon Islands. Our larger goals include setting up a Kwaio CSO to manage conservation activities in the area (see “Project Objectives” below), protect and conserve priority species on Malaita, and in the longer-term, work toward creating Protected Areas to protect globally threatened species. We also hope the project will serve as a conservation model for other Malaitan and Solomon Islands communities. The project is taking place with people of the Kwaio language group. The mountain Kwaio people are the largest Solomon Islands group still practicing their indigenous ancestral religion. The biodiversity conservation project is documenting the deep local knowledge of medicinal plants and bush foods found in the rainforest of Malaita, and building capacity to undertake similar projects in the future.
Development of a preventive strategy for rheumatic heart disease using an experimental model (Old ID 19355)
Catherine Rush
01 Jan 2012 - 31 Dec 2016
Based on animal studies, we aim to demonstrate that the worsening of heart damage seen in patients with rheumatic heart disease (RHD) is due to repeated infections with bacteria (group A streptococci: GAS). The heart damage is caused by continual immune damage to the heart and valves and this has adverse effects on heart function. We will also investigate a novel way to prevent the development of RHD.
A randomised controlled trial of intravenous paracetamol and oral paracetamol to control acute pain (Old ID 21779)
Venkat Vangaveti
01 Jan 2015 - 27 Oct 2016
The objective of this project is to provide evidence that intravenous paracetamol produces superior analgesia than oral paracetamol in the ED setting. Secondary objectives include providing evidence that IV paracetamol produces good patient satisfaction, few side effects and reduced length of hospital stay. The trial is designed as a prospective double blind randomised controlled trial with two parallel groups. 50 patients will receive placebo oral intervention and a 1g intravenous paracetamol formulation. The other 50 patients will receive 1g oral paracetamol and IV normal saline. Patients will be requested to chart their pain prior to analgesia and then at 15 minute intervals for the first hour and half hourly for the following 3 hours. Side effects, length of ED stay and patient satisfaction will also be recorded to assess the secondary objectives.
Evaluation of QAIHC Sexual Health and Wellbeing Project. (Old ID 27405)
Rebecca Evans
22 Oct 2021 - 22 Jan 2023
The overall goal of the QAIHC Sexual Health and Wellbeing Project is to improve Sexually transmissible infection (STI) and blood borne virus (BBVs) services in QAIHC Member Services and to work towards reducing the number of Aboriginal and Torres Strait Islander positive notifications. To help achieve this, support is provided for Member Services to implement models of care aimed to increase client engagement, education opportunities, as well as improve screening, notification and treatment rates. Tools, resources and support are provided to participant health services to implement sexual health and wellbeing activities that are culturally safe, led by Aboriginal and Torres Strait Islander health workers and tailored to the Aboriginal and Torres Strait Islander model of care. The aim of this work is to evaluate the implementation, impact and outcomes of the QAIHC Sexual Health and Wellbeing Project.
Regenerating lizard tails: A new model for investigating lymphangiogenesis
- 2003
- Researchers:Suzy Munns
Association of osteoprotegerin with human abdominal aortic aneurysm progression
- 2005
- American Heart Association
- Researchers:Jonathan Golledge
A simple plan: cnidarians and the origins of developmental mechanisms
- 2004
- Nature Publishing
- Researchers:David Miller
Start Date:
01 Jan 2011
Start Date:
01 Jan 2015
Title:
MPHTM, James Cook University
End Date:
01 Jan 2009
End Date:
01 Jan 2014
Title:
Italian
Start Date:
01 Jan 2013
Start Date:
01 Jan 2016
Title:
"Tuberculosis in rural PNG: T cell biomarkers for diagnosis and monitoring treatment", $53,000.
Start Date:
01 Jan 2016
Start Date:
01 Jan 2009
Start Date:
01 Jan 2012